pubmed-article:18487388 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18487388 | lifeskim:mentions | umls-concept:C0007134 | lld:lifeskim |
pubmed-article:18487388 | lifeskim:mentions | umls-concept:C0205462 | lld:lifeskim |
pubmed-article:18487388 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
pubmed-article:18487388 | lifeskim:mentions | umls-concept:C0850292 | lld:lifeskim |
pubmed-article:18487388 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
pubmed-article:18487388 | lifeskim:mentions | umls-concept:C1705938 | lld:lifeskim |
pubmed-article:18487388 | lifeskim:mentions | umls-concept:C1527178 | lld:lifeskim |
pubmed-article:18487388 | pubmed:issue | 966 | lld:pubmed |
pubmed-article:18487388 | pubmed:dateCreated | 2008-5-19 | lld:pubmed |
pubmed-article:18487388 | pubmed:abstractText | Percutaneous image-guided ablation with the use of radiofrequency has recently received much attention as a minimally invasive technique for the treatment of solid malignancies. Renal cell carcinomas (RCCs) were among the first extrahepatic tumours to be targeted with radiofrequency ablation (RFA). The aim of this study is to present the efficacy of RFA in RCC and the factors that have an impact on the attained necrosis with regards to the histological findings. | lld:pubmed |
pubmed-article:18487388 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18487388 | pubmed:language | eng | lld:pubmed |
pubmed-article:18487388 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18487388 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:18487388 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18487388 | pubmed:month | Jun | lld:pubmed |
pubmed-article:18487388 | pubmed:issn | 1748-880X | lld:pubmed |
pubmed-article:18487388 | pubmed:author | pubmed-author:ThanosLL | lld:pubmed |
pubmed-article:18487388 | pubmed:author | pubmed-author:MylonaSS | lld:pubmed |
pubmed-article:18487388 | pubmed:author | pubmed-author:NtaiSS | lld:pubmed |
pubmed-article:18487388 | pubmed:author | pubmed-author:StroumpouliEE | lld:pubmed |
pubmed-article:18487388 | pubmed:author | pubmed-author:GlentzesVV | lld:pubmed |
pubmed-article:18487388 | pubmed:author | pubmed-author:MartinisSS | lld:pubmed |
pubmed-article:18487388 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18487388 | pubmed:volume | 81 | lld:pubmed |
pubmed-article:18487388 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18487388 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18487388 | pubmed:pagination | 479-84 | lld:pubmed |
pubmed-article:18487388 | pubmed:dateRevised | 2009-2-2 | lld:pubmed |
pubmed-article:18487388 | pubmed:meshHeading | pubmed-meshheading:18487388... | lld:pubmed |
pubmed-article:18487388 | pubmed:meshHeading | pubmed-meshheading:18487388... | lld:pubmed |
pubmed-article:18487388 | pubmed:meshHeading | pubmed-meshheading:18487388... | lld:pubmed |
pubmed-article:18487388 | pubmed:meshHeading | pubmed-meshheading:18487388... | lld:pubmed |
pubmed-article:18487388 | pubmed:meshHeading | pubmed-meshheading:18487388... | lld:pubmed |
pubmed-article:18487388 | pubmed:meshHeading | pubmed-meshheading:18487388... | lld:pubmed |
pubmed-article:18487388 | pubmed:meshHeading | pubmed-meshheading:18487388... | lld:pubmed |
pubmed-article:18487388 | pubmed:meshHeading | pubmed-meshheading:18487388... | lld:pubmed |
pubmed-article:18487388 | pubmed:meshHeading | pubmed-meshheading:18487388... | lld:pubmed |
pubmed-article:18487388 | pubmed:meshHeading | pubmed-meshheading:18487388... | lld:pubmed |
pubmed-article:18487388 | pubmed:meshHeading | pubmed-meshheading:18487388... | lld:pubmed |
pubmed-article:18487388 | pubmed:meshHeading | pubmed-meshheading:18487388... | lld:pubmed |
pubmed-article:18487388 | pubmed:meshHeading | pubmed-meshheading:18487388... | lld:pubmed |
pubmed-article:18487388 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18487388 | pubmed:articleTitle | Renal cell carcinoma radiofrequency ablation: evaluation of efficacy based on histological correlation. | lld:pubmed |
pubmed-article:18487388 | pubmed:affiliation | Department of Radiology, "Korgialenio Benakio" Red Cross Hospital of Athens, Athanasaki St 1, 11526 Athens, Greece. sofimylona@yahoo.com | lld:pubmed |
pubmed-article:18487388 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18487388 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18487388 | lld:pubmed |